series-c-plus
Stage
2
Investors
About
Cerevel Therapeutics is a biopharmaceutical company developing and commercializing therapies for neuroscience disorders, including Parkinson's disease, schizophrenia, and other central nervous system conditions.
Explore Cerevel Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.